Objectives This retrospective cohort study assessed the clinical effectiveness of
nirmatrelvirplus ritonavir (NMV-r) in treating COVID-19 in patients with liver cirrhosis (LC) …

Objectives This study investigated the association between nirmatrelvir plus ritonavir (NMV-
r) or molnupiravir and the outcomes of non-hospitalized high-risk patients with COVID-19 …

The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …

Although a novel oral antiviral agent can improve short‐term COVID‐19 outcomes, its effects
on the long‐term outcomes, namely the risk of major adverse cardiovascular events …

Objective To investigate the association between nirmatrelvir plus ritonavir (NMV-r) and the
outcomes of non-hospitalized obese patients with coronavirus disease 2019 (COVID-19) …

This study investigated the clinical effectiveness of nirmatrelvir plus ritonavir (NMV‐r) on
short‐term outcome and the risk of postacute sequelae of severe acute respiratory syndrome …

This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV‐r) in treating
patients with coronavirus disease‐2019 (COVID‐19) and substance use disorders (SUDs) …

The retrospective cohort was conducted to assess the effect of nirmatrelvir‐ritonavir (NMV‐r)
on the long‐term risk of neuropsychiatric sequela following COVID‐19. TriNetX research …

Objectives This study aimed to investigate the association between vitamin D deficiency
(VDD) and post-acute outcomes of severe acute respiratory syndrome coronavirus 2 (SARS …

The rise of methicillin-resistant Staphylococcus aureus (MRSA) poses a significant
challenge in clinical settings due to its ability to evade conventional antibiotic treatments …